HIV-related lipodystrophy and related factorsTERSHAKOVEC, Andrew M; FRANK, Ian; RADER, Daniel et al.Atherosclerosis. 2004, Vol 174, Num 1, pp 1-10, issn 0021-9150, 10 p.Article

Comparisons of Apolipoprotein B Levels Estimated by Immunoassay, Nuclear Magnetic Resonance, Vertical Auto Profile, and Non-High-Density Lipoprotein Cholesterol in Subjects With Hypertriglyceridemia (SAFARI Trial)GRUNDY, Scott M; LENA VEGA, Gloria; TOMASSINI, Joanne E et al.The American journal of cardiology. 2011, Vol 108, Num 1, pp 40-46, issn 0002-9149, 7 p.Article

Correlation of Measures of Pain, Function, and Overall Response : Results Pooled From Two Identical Studies of Etoricoxib in Chronic Low Back PainSHELDON, Eric A; BIRD, Steven R; SMUGAR, Steven S et al.Spine (Philadelphia, PA. 1976). 2008, Vol 33, Num 5, pp 533-538, issn 0362-2436, 6 p.Article

Behavior therapy and sibutramine for the treatment of adolescent obesity: A randomized controlled trialBERKOWITZ, Robert I; WADDEN, Thomas A; TERSHAKOVEC, Andrew M et al.JAMA, the journal of the American Medical Association. 2003, Vol 289, Num 14, pp 1805-1812, issn 0098-7484, 8 p.Article

Correlation of Non-High-Density Lipoprotein Cholesterol and Low-Density Lipoprotein Cholesterol With Apolipoprotein B During Simvastatin + Fenofibrate Therapy in Patients With Combined Hyperlipidemia (A Subanalysis of the SAFARI Trial)GRUNDY, Scott M; VEGA, Gloria Lena; TOMASSINI, Joanne E et al.The American journal of cardiology. 2009, Vol 104, Num 4, pp 548-553, issn 0002-9149, 6 p.Article

Influence of age, gender, and race on the efficacy of adding ezetimibe to atorvastatin vs. atorvastatin up-titration in patients at moderately high or high risk for coronary heart diseaseBAYS, Harold E; CONARD, Scott E; LEITER, Lawrence A et al.International journal of cardiology. 2011, Vol 153, Num 2, pp 141-147, issn 0167-5273, 7 p.Article

Rofecoxib 50 mg and valdecoxib 20 or 40 mg in adults and adolescents with postoperative pain after third molar extraction : Results of two randomized, double-blind, placebo-controlled, single-dose studiesDANIELS, Stephen E; DESJARDINS, Paul J; BIRD, Steven R et al.Clinical therapeutics. 2006, Vol 28, Num 7, pp 1022-1034, issn 0149-2918, 13 p.Article

Effects of ezetimibe added to statin therapy on markers of cholesterol absorption and synthesis and LDL-C lowering in hyperlipidemic patientsTHONGTANG, Nuntakorn; JIANXIN LIN; SCHAEFER, Ernst J et al.Atherosclerosis. 2012, Vol 225, Num 2, pp 388-396, issn 0021-9150, 9 p.Article

Safety and Efficacy of Ezetimibe Added on to Rosuvastatin 5 or 10 mg Versus Up-Titration of Rosuvastatin in Patients With Hypercholesterolemia (the ACTE Study)BAYS, Harold E; DAVIDSON, Michael H; MASSAAD, Rachid et al.The American journal of cardiology. 2011, Vol 108, Num 4, pp 523-530, issn 0002-9149, 8 p.Article

Lipid-Altering Efficacy and Safety of Ezetimibe/Simvastatin Versus Atorvastatin in Patients With Hypercholesterolemia and the Metabolic Syndrome (from the VYMET Study)ROBINSON, Jennifer G; BALLANTYNE, Christie M; GRUNDY, Scott M et al.The American journal of cardiology. 2009, Vol 103, Num 12, pp 1694-1702, issn 0002-9149, 9 p.Article

Total and low-density lipoprotein cholesterol in high-risk patients treated with atorvastatin monotherapy in the United Kingdom: analysis of a primary-care databaseJAMESON, Kevin; QIAOYI ZHANG; CHANGGENG ZHAO et al.Current medical research and opinion. 2014, Vol 30, Num 4, pp 655-665, issn 0300-7995, 11 p.Article

Lipid Lowering for Secondary Prevention of Cardiovascular Disease in Older AdultsTHOMAS, Joseph E; TERSHAKOVEC, Andrew M; JONES-BURTON, Charlotte et al.Drugs & aging. 2010, Vol 27, Num 12, pp 959-972, issn 1170-229X, 14 p.Article

Pooled Analyses of Effects on C-Reactive Protein and Low Density Lipoprotein Cholesterol in Placebo-Controlled Trials of Ezetimibe Monotherapy or Ezetimibe Added to Baseline Statin TherapyPEARSON, Thomas A; BALLANTYNE, Christie M; VELTRI, Enrico et al.The American journal of cardiology. 2009, Vol 103, Num 3, pp 369-374, issn 0002-9149, 6 p.Article

Effect of LDL Cholesterol and Treatment With Losartan on End-Stage Renal Disease in the RENAAL StudyTERSHAKOVEC, Andrew M; KEANE, William F; ZHONGXIN ZHANG et al.Diabetes care. 2008, Vol 31, Num 3, pp 445-447, issn 0149-5992, 3 p.Article

Effect of Extended-Release Niacin on New-Onset Diabetes Among Hyperlipidemic Patients Treated With Ezetimibe/Simvastatin in a Randomized Controlled TrialGUYTON, John R; FAZIO, Sergio; ADEWALE, Adeniyi J et al.Diabetes care. 2012, Vol 35, Num 4, pp 857-860, issn 0149-5992, 4 p.Article

Long-Term Safety and Efficacy of Triple Combination Ezetimibe/Simvastatin Plus Extended-Release Niacin in Patients With HyperlipidemiaFAZIO, Sergio; GUYTON, John R; POLIS, Adam B et al.The American journal of cardiology. 2010, Vol 105, Num 4, pp 487-494, issn 0002-9149, 8 p.Article

Safety and Efficacy of Ezetimibe/Simvastatin Combination Versus Atorvastatin Alone in Adults ≥65 Years of Age With Hypercholesterolemia and With or at Moderately High/High Risk for Coronary Heart Disease (the VYTELD Study)FOODY, Joanne M; VIRGIL BROWN, W; ZIEVE, Franklin et al.The American journal of cardiology. 2010, Vol 106, Num 9, pp 1255-1263, issn 0002-9149, 9 p.Article

Efficacy and Safety of Ezetimibe Added on to Atorvastatin (20 mg) Versus Uptitration of Atorvastatin (to 40 mg) in Hypercholesterolemic Patients at Moderately High Risk for Coronary Heart DiseaseCONARD, Scott E; BAYS, Harold E; LEITER, Lawrence A et al.The American journal of cardiology. 2008, Vol 102, Num 11, pp 1489-1494, issn 0002-9149, 6 p.Article

A double-blind randomized controlled trial of rofecoxib and multidose oxycodone/acetaminophen in dental impaction painDESJARDINS, Paul J; BLACK, Peter M; DANIELS, Stephen E et al.Journal of oral and maxillofacial surgery. 2007, Vol 65, Num 8, pp 1624-1632, issn 0278-2391, 9 p.Article